➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Johnson and Johnson
Merck
McKinsey
Dow

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Litigation Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

Small Molecule Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.
Biologic Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2006-11-21 111 Exhibit A (Part 3) consuitation 253:13 consulted 250117 256:18 257:4,11 258:6,25 consulting 230:13 contact 133:5,13 156:12…the '086 patent, which 24 certainly not prepared to render in this 25 was the patent that intervened…appiication, the '94`7 18 uitimately ied to the ‘812 patent? 18 appiication, after you received this restriction…determine if there Was one, if you wish me to. 22 patent, would that be consistent with the 23 Q. So just…vague. 14 through 4 that are now in the '812 patent, if 15 A. Do you mean if 1 had submitted 15 you External link to document
2007-05-14 151 Appendix part 3 5716 10257:581? 10:5?:5919 10:5320019 10:58:0220 10:58:0621 22 23 24 t 25 231 Q. So lam just trying…who are patent 7 27796. B agents at Boehringer also? B A. Yes. 9 A. Yes, patent attorneys, patent 9 Q. And…three United States patents - U.S. Patent Nos. 4,'731,374 {“the ’3'74 patent"), 4,843,086 … the ‘{}86 patent and the `812 patent l have also been asked to compare these U.S. patents to two earlier…you would have to 11 : 0 6 : 05 20 the patent office, a patent office that one 11:02:3621 oddressa specialist External link to document
2007-08-16 171 Redacted Document owner of U.S. Patent No. 4,866,812 (whichi will refer to as “the ‘812 Patent” or “the patent-in-suit"…and court eertitied” expert on patent matters before the Austrian Patent Court. I first was entered on …courses on patent law and procedure I am_ also a Direetor of the Diplorna Course on Patent Litigation…information to a European patent application that claimed priority &om two German patent applications was…812 patent"). ln response, Barr has alleged several defenses, including that the ‘8 12 patent is External link to document
2006-01-27 18 Exhibit is the owner of United States Patent No. 5, 246, 937 ("the 937 Patent"). Complaint at ll 9. Pursuant…motion is denied. BACKGROUND The instant case is a patent infringement action arising under the Hatch-Waxman…Certification") with respect to Novartis' 937 patent, Id. at ll l3. Teva's Paragraph IV Certification…Filed 01/27/2006 Page l Of 2 Page 1 that the 937 patent is invalid or would not be infringed by Teva'…any valid or enforceable claim of Novartis' patents. Id. at ll l$. On April 8, 2005, after receipt External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Johnson and Johnson
Moodys
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.